OPKO Health, Inc. (NASDAQ:OPK) Q3 2015 Results Earnings Conference Call November 9, 2015 4:30 PM ET
Executives
Anne Marie Fields - LHA, Investor Relations
Dr. Phillip Frost - Chairman and CEO
Steve Rubin - Executive Vice President
Adam Logal - Chief Financial Officer
Charlie Bishop - CEO, Renal Division
Analysts
Dana Flanders - JPMorgan
Brandon Couillard - Jefferies
Rohit Vanjani - Oppenheimer
Kevin DeGeeter - Ladenburg
Yale Jen - Laidlaw
Operator
Welcome to the OPKO Health Third Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode. Following management’s prepared remarks we will hold a Q&A session. [Operator Instructions]
As a reminder, this conference is being recorded, November 9, 2015. I would now like to turn the conference over to Anne Marie Fields. Please go ahead, ma’am.
Anne Marie Fields
Thank you. Thank you and good afternoon. Before we begin, I'd like to remind you that any statements made during this call which are historical will be considered forward-looking, and as such will be subject to risk and uncertainties, which could materially affect the company’s expected results, including without limitation the various risks described in the company’s annual report on Form 10-K for the year ended December 31, 2014, and its subsequent filings with the SEC.
I'd like to discuss the format for today's call. Dr. Phillip Frost will provide brief opening remarks, followed by Steve Rubin, OPKO’s Executive Vice President, who will provide an update on the company’s business operations, followed by Adam Logal, OPKO’s Chief Financial Officer, who will review the financial results and then Dr. Frost will follow with closing remarks, after which they are here to answer any questions you might have.
I would now like to turn the call to Dr. Phillip Frost, Chairman and CEO of OPKO Health. Dr. Frost?
- Read more current OPK analysis and news
- View all earnings call transcripts